Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Per Fransson(Umeå University), Per Nilsson(Lund University), Adalsteinn Gunnlaugsson(Lund University), L. Beckman(Sundsvall Municipality), Björn Tavelin(Umeå University), David Norman(Umeå University), Camilla Thellenberg‐Karlsson(Umeå University), Morten Høyer(Aarhus University Hospital), Magnus Lagerlund, Jon Kindblom(University of Gothenburg), Claes Ginman(Karlstad Central Hospital), Bengt Johansson(Örebro University Hospital), Kirsten Björnlinger(Ryhov Hospital Jönköping), M. Seke(Centrallasarettet Växjö), Måns Agrup(Linköping University Hospital), Björn Zackrisson(Umeå University), Elisabeth Kjellén(Skåne University Hospital), Lars Franzén(Umeå University), Anders Widmark(Umeå University)
The Lancet Oncology
January 13, 2021
Cited by 156

Abstract


Related Papers

No related papers found

Powered by citation graph analysis